We may soon be facing the end of the “antibiotic era.” The initial and seemingly unstoppable
success of antibiotics, the fruit of human ingenuity, has been countered by an escalation of …

… Acinetobacter baumannii is a leading cause of nosocomial … We mapped the global prevalence
of multidrug-resistant A. … , and hence it is challenging to define whether they are native …

… baumannii. In Latin America, a lineage different from … global world with migration and
increasing use of antimicrobials, multidrug-resistant bacteria will continue to adapt and challenge …

Acinetobacter baumannii is an opportunistic nosocomial pathogen and one of the six most
important multidrug resistant microorganisms in hospitals worldwide. This human pathogen is …

… Our study highlights the emerging challenges entailed in the WGS-powered epidemiological
surveillance of globally distributed clonal groups. Standardization is urgently required …

… Acinetobacter baumannii (CRAB) has become one of the leading causes of healthcare-associated
infections globally… have been recognized as a global challenge because of its multiple…

… Acinetobacter baumannii is one such pathogen that has been … It is one of the most
challenging hospital-acquired pathogens as … Acinetobacter baumannii is an opportunistic human …

… Acinetobacter baumannii (named in honor of the American bacteriologists Paul and Linda
Baumann) is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial …

… is a global challenge, it would … global scale. Further efforts, including potentially compulsory
surveillance and data gathering, are required in order to properly face this global challenge. …

… Acinetobacter baumannii infections have … baumannii clinical isolates are frequently
resistant to most antimicrobial agents and evidence of pan-drug resistance among A. baumannii …